Literature DB >> 19112733

Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy.

Giuliano Grazzini1.   

Abstract

Mesh：

Year:  2008        PMID： 19112733      PMCID： PMC2626912          DOI： 10.2450/2008.0049-07

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  6 in total

1.  Evidence-based practice of transfusion medicine: is it possible and what do the words mean?

Authors:  Eleftherios C Vamvakas
Journal:  Transfus Med Rev       Date:  2004-10

2.  Evidence based medicine has come a long way.

Authors:  Gordon Guyatt; Deborah Cook; Brian Haynes
Journal:  BMJ       Date:  2004-10-30

3.  Teaching evidence based medicine.

Authors:  Chris Del Mar; Paul Glasziou; Dan Mayer
Journal:  BMJ       Date:  2004-10-30

Review 4.  The European Union Blood Safety Directive and its implications for blood services.

Authors:  E Angela E Robinson
Journal:  Vox Sang       Date:  2007-08       Impact factor: 2.144

Review 5.  Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?

Authors:  J D Rizzo
Journal:  Best Pract Res Clin Haematol       Date:  2005       Impact factor: 3.020

6.  Clinicians as gatekeepers: what is the best route to optimal blood use?

Authors:  J P Isbister
Journal:  Dev Biol (Basel)       Date:  2007
  6 in total
  10 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

2.  Appropriateness of blood transfusion and physicians' education: a continuous challenge for Hospital Transfusion Committees?

Authors:  Giancarlo Maria Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

Review 3.  Evaluation of clinical appropriateness of blood transfusion.

Authors:  Franco Verlicchi
Journal:  Blood Transfus       Date:  2010-04       Impact factor: 3.443

4.  Regulatory requirements and standards on clinical appropriateness of blood component transfusion.

Authors:  Paul Strengers
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

Review 5.  Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

Authors:  Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Liviana Catalano; Rosa Chianese; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 6.  The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.

Authors:  Gabriele Calizzani; Stefania Vaglio; Fabio Candura; Samantha Profili; Monica Lanzoni; Karen Cristiano; Maria Rita Tamburrini; Giuliano Grazzini; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

7.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

8.  Blood transfusion practice: a nationwide survey in Italy.

Authors:  Franco Verlicchi; Giuseppina Facco; Michela Macrì; Stefano Antoncecchi; Pietro Bonomo
Journal:  Blood Transfus       Date:  2011-05-12       Impact factor: 3.443

9.  Institutional authorisation and accreditation of Transfusion Services and Blood Donation Sites: results of a national survey.

Authors:  Giancarlo Maria Liumbruno; Valentina Panetta; Rosaria Bonini; Rosa Chianese; Francesco Fiorin; Maria Antonietta Lupi; Ivana Tomasini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2011-05-31       Impact factor: 3.443

10.  Red cell transfusion in orthopaedic surgery: a benchmark study performed combining data from different data sources.

Authors:  Franco Verlicchi; Fausto Desalvo; Gabriele Zanotti; Loretta Morotti; Ivana Tomasini
Journal:  Blood Transfus       Date:  2011-04-12       Impact factor: 3.443
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.